Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Dyne Therapeutics(US:DYN) Globenewswire·2025-07-29 04:10- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 in DMD fully enrolled to support potential submission for U.S. Accelerated Approval in early 2026 - - Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 ongoing to support potential submission for U.S. Accelerated Approval in late 2026 - WALTHAM, Mass., July 28, 2025 (GLOBE N ...